Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IP
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Janice Gabrilove Martin S. Tallman Elisabeth Paietta |
| Publication date | July 4, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |